Lixte Biotechnology Holdings, Inc. (LIXT)

LIXT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.11	1.04	4.2	5.35	4.82
Cash & Short-Term Investments	5.11	1.04	4.2	5.35	4.82
Cash Growth	391.54%	-75.28%	-21.48%	10.98%	-4.84%
Other Current Assets	0.07	0.11	0.11	0.21	0.27
Total Current Assets	5.18	1.15	4.31	5.56	5.09
Net Property, Plant & Equipment	7.56	-	-	-	-
Total Assets	12.73	1.15	4.31	5.56	5.09
Accounts Payable	0.44	0.08	0.16	0.23	0.23
Current Portion of Leases	0.6	-	-	-	-
Unearned Revenue	0.23	0.24	0.16	0.17	0.08
Other Current Liabilities	0.07	-	-	-	-
Total Current Liabilities	1.33	0.32	0.31	0.4	0.3
Long-Term Leases	0.44	-	-	-	-
Total Long-Term Liabilities	0.44	-	-	-	-
Total Liabilities	1.77	0.32	0.31	0.4	0.3
Preferred Stock	1.73	3.5	3.5	3.5	3.5
Common Stock	0	0	0	0	0
Additional Paid-in Capital	66.01	49.39	48.98	45.06	38.37
Retained Earnings	-58.08	-52.07	-48.48	-43.39	-37.08
Minority Interest	1.3	-	-	-	-
Shareholders' Equity	9.66	0.83	3.99	5.17	4.79
Total Liabilities & Equity	12.73	1.15	4.31	5.56	5.09
Total Debt	1.03	0	0	0	0
Net Cash (Debt)	4.07	1.04	4.2	5.35	4.82
Net Cash Growth	291.98%	-75.28%	-21.48%	10.98%	-4.84%
Net Cash Per Share	0.84	0.46	2.19	3.38	3.58
Book Value	9.66	0.83	3.99	5.17	4.79
Book Value Per Share	2.00	0.37	2.09	3.26	3.56
Tangible Book Value	9.66	0.83	3.99	5.17	4.79
Tangible Book Value Per Share	2.00	0.37	2.09	3.26	3.56

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q